Nagaokakyo, Japan

Takushi Matsuzaki

This inventor holds 1 USPTO granted patent. Top assignee: Nippon Shinyaku Company, Ltd.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takushi Matsuzaki. Retrieved from https://idiyas.com/inventor/takushi-matsuzaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takushi Matsuzaki: Innovator in Isoquinoline Derivatives

Introduction

Takushi Matsuzaki is a prominent inventor based in Nagaokakyo, Japan. He is known for his significant contributions to the field of pharmaceuticals, particularly in the development of isoquinoline derivatives. His work has led to advancements in drug formulation and therapeutic applications.

Latest Patents

Matsuzaki holds a patent for isoquinoline derivatives and drugs. This innovation showcases his expertise in medicinal chemistry and highlights the potential of these compounds in treating various medical conditions. His patent portfolio includes 1 patent that reflects his commitment to advancing pharmaceutical science.

Career Highlights

Matsuzaki is affiliated with Nippon Shinyaku Company, Ltd., where he has been instrumental in research and development efforts. His role at the company has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to innovative drug solutions.

Collaborations

Throughout his career, Matsuzaki has worked alongside notable colleagues such as Hiroyoshi Hidaka and Akira Matsuura. These collaborations have fostered a dynamic environment for innovation and have led to the successful development of new pharmaceutical products.

Conclusion

Takushi Matsuzaki's work in isoquinoline derivatives exemplifies the impact of dedicated inventors in the pharmaceutical industry. His contributions continue to influence drug development and improve therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…